FIBROGAMMIN

This brand name is authorized in Austria, Brazil, France, Israel, Japan, Lithuania, UK.

Active ingredients

The drug FIBROGAMMIN contains one active pharmaceutical ingredient (API):

1	Coagulation factor XIII UNII NU23Q531G1 - CATRIDECACOG
	Factor XIII connects the amino group of lysine with glutamine via its enzymatic function (transamidase activity), thereby leading to the cross-linking of fibrin molecules. This is the final stage of blood coagulation. Fibrin cross-linking and stabilisation promote the penetration of fibroblasts and support wound healing.
	Read more about Coagulation factor XIII

Medication package inserts

Below package inserts are available for further reading:

Document	Type	Information Source
FIBROGAMMIN Powder and solvent for solution for injection	MPI, EU: SmPC	Medicines & Healthcare Products Regulatory Agency (GB)

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC Group		Classification
B02BD07	Coagulation factor XIII	B Blood and blood forming organs → B02 Antihemorrhagics → B02B Vitamin K and other hemostatics → B02BD Blood coagulation factors
Discover more medicines within B02BD07

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
BR	Câmara de Regulação do Mercado de Medicamentos	502600801150415, 502615080007503
FR	Base de données publique des médicaments	66885235
GB	Medicines & Healthcare Products Regulatory Agency	308203, 47697
IL	מִשְׂרַד הַבְּרִיאוּת	6343
JP	医薬品医療機器総合機構	6343431D2020
LT	Valstybinė vaistų kontrolės tarnyba	1079129